EyeSouth Partners Enters Ninth State with Scott & Christie Eyecare Associates of Pennsylvania Affiliation

EyeSouth Partners (“EyeSouth” or “the Company”) is pleased to announce that it has completed an affiliation with Scott & Christie Eyecare Associates (“S&C”). The affiliation represents EyeSouth’s first in the state of Pennsylvania and twenty-sixth affiliation overall.

EyeSouth is an eye care-focused management services organization backed by Shore Capital Partners, a Chicago-based private equity firm. The company is committed to partnering with leading physicians to build a premier network of eye care services in the U.S. EyeSouth’s affiliate network consists of 26 practices with over 220 doctors providing medical and surgical eye care services at over 120 locations, including 15 surgery centers throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania, and Alabama.

Scott & Christie Eyecare Associates is an ophthalmology medical group that has served the Greater Pittsburgh area for over 70 years, led by the physician team of Dr. William Christie and Dr. Christopher Spearman, as well as Jeff Rihn, Chief Financial Officer of the practice. S&C provides an integrated service model incorporating the latest advancements in cataract surgery, glaucoma surgery, primary eye care, and clinical research.

“We are excited to partner with EyeSouth and believe this partnership will enable our practice to direct our focus to enhanced patient care and cutting-edge research efforts,” said Dr. Christie. “We look forward to leveraging resources within the EyeSouth network as we continue to grow our presence in the Greater Pittsburgh area.”

“We are excited to expand our presence into the state of Pennsylvania with a highly-respected Ophthalmology practice in Scott & Christie Eyecare Associates,” said Dr. Eugene Gabianelli, M.D., Chief Medical Officer of EyeSouth Partners. “S&C also brings a unique value to the EyeSouth network through their relentless focus on top-quality medical care and their leading clinical research efforts in the ophthalmology field.”

To learn more about partnering with EyeSouth Partners, visit www.eyesouthpartners.com or contact Jason Shafer, Chief Development Officer, at jason.shafer@eyesouthpartners.com.

About EyeSouth Partners

Headquartered in Atlanta, GA, EyeSouth Partners (“EyeSouth”) is an eye care management services organization committed to partnering with leading physicians to build a premier network of eye care services throughout the U.S. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with strategic guidance, administrative resources, operating expertise, and capital with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of over 220 doctors providing medical and surgical eye care services at over 120 locations throughout Georgia, Texas, Louisiana, Florida, Tennessee, Ohio, Kentucky, Pennsylvania and Alabama. EyeSouth is backed by Shore Capital Partners, a Chicago-based private equity firm. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com.

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services and Real Estate industries. Shore supports management partners with capital, business development expertise and industry knowledge to accelerate growth, fund acquisitions and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow and significant growth potential, including organic growth and growth through industry consolidation. Shore has $2 billion of equity capital under management through various investment vehicles. For more information, please visit: www.shorecp.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.